optimizes parenchymal preservation with a promising short-term oncologic outcome than standard partial nephrectomy (SPN), however, long-term oncologic outcomes for TE after minimally invasive surgery are scarce in the literature. We aim to provide longterm oncologic outcomes after laparoscopic and robotic tumor enucleation for renal cell carcinoma (RCC) in a tertiary medical center in this study.
INTRODUCTION AND OBJECTIVES: Tumor enucleation (TE)
optimizes parenchymal preservation with a promising short-term oncologic outcome than standard partial nephrectomy (SPN), however, long-term oncologic outcomes for TE after minimally invasive surgery are scarce in the literature. We aim to provide longterm oncologic outcomes after laparoscopic and robotic tumor enucleation for renal cell carcinoma (RCC) in a tertiary medical center in this study.
METHODS: We retrospectively analyzed 146 consecutive patients who underwent TE with either laparoscopic or robotic approach for localized RCC between 2009 and 2017. Local recurrence, cancerspecific survival(CSS) and overall survival(OS) were the main outcomes of this study. Survival curves were generated using a Kaplan-Meier method. Perioperative outcomes and pathological outcomes were also analyzed.
RESULTS: Overall, 106 male and 40 female patients were eligible for the study. Laparoscopic TE was applied to 108 patients and robotic TE was used for 38 patients. The median tumor size was 3.4cm with a median RENAL score of 7. Warm ischemia was used in all patients and median ischemia time was 20 minutes. Two patients (1.4%) had major complications(Clavien IIIa). The median global GFR preserved at 1 year after surgery was 93%. Peritumoral pseudocapsule was present in 142 (97.2%) tumors with a median thickness of 0.36mm. Pseudocapsule invasion was reported in 50 tumors (34%). Positive surgical margins were reported in 3/ 146 (2.1%) tumors. At a median follow-up of 62 months, local recurrence happened in 1 patient (0.7%). The 5-year actuarial cancer-specific survival and overall survival were 95.9% and 92.5%, respectively.
CONCLUSIONS: This study indicates that tumor enucleation with laparoscopic or robotic approach in experienced hands for the treatment of RCC appears oncologically safe at a median follow-up of more than 5 years. TE can achieve negative surgical margins and thus prevent local recurrence due to the existence of pseudocapsule in the vast majority of patients. Prospective studies with longer followup will be required to further evaluate oncologic safety after TE.
Source of Funding: None

MP31-19 LONG-TERM FOLLOW-UP OF RENAL FUNCTION AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER PARTIAL NEPHRECTOMY
Takashi Ikeda*, Toshio Takagi, Hiroki Ishihara, Hironori Fukuda, Kazuhiko Yoshida, Junpei Iizuka, Hirohito Kobayashi, Masayoshi Okumi, Hideki Ishida, Tsunenori Kondo, Kazunari Tanabe, Tokyo, Japan INTRODUCTION AND OBJECTIVES: Renal function preservation is an important goal of partial nephrectomy (PN). Renal function after PN declines owing to ischemic injury and loss of parenchymal volume. Although a relatively long-term follow-up of renal function after PN has been reported, renal function change in a robust number of patients from a single institution is rarely reported. In the present study, we assessed renal function change after PN for more than 3 years and analyzed the predictive factors for the development of chronic kidney disease (CKD) stage.
METHODS: The data from 741 patients who underwent PN between 2003 and 2018 and who could be followed up for at least 3 years was retrospectively evaluated. The preoperative and postoperative estimated glomerular filtration rate (eGFR) was calculated and predictors associated with the development of CKD were studied using the univariate and multivariate logistic regression analyses.
RESULTS: The patients' mean age was 60 years, and the mean tumor size was 30 mm. CONCLUSIONS: Three years' follow-up after PN revealed that 405 patients (54.7%) developed CKD. Age, tumor size, and surgical procedure were independent predictors of the development of CKD after PN.
Source of Funding: none
MP31-20 ELIMINATION OF ROUTINE SURGICAL DRAINS IS SAFE IN ROBOTIC-ASSISTED PARTIAL NEPHRECTOMIES
INTRODUCTION AND OBJECTIVES: To prospectively evaluate outcomes and complications of robotic-assisted partial nephrectomy (RAPN) following elimination of post-operative surgical drains.
METHODS: 360 consecutive robotic partial nephrectomies (RAPNs) performed by a single surgeon were analyzed from a prospectively-maintained database. Routine intraoperative placement of surgical drains was stopped at case 260. The subsequent 100 patients without drains and preceding 100 cases with drains were included in analysis for a cohort of 200 patients. Variables analyzed included pre-operative patient and tumor characteristics and postoperative outcomes, including serum and drain creatinine on postoperative day 1, estimated glomerular filtration rate (eGFR) at 1 day and 1 month after surgery, length of hospital stay(LOS), and complications. Complications were categorized according to the Clavien-Dindo classification.
RESULTS: For patients in whom a drain was placed intraoperatively, mean drain duration was 2.2 days. Mean drain creatinine to serum creatinine ratio was 1.06. 3% of patients had a drain creatinine to serum creatinine ratio > 1.2 prior to removal of drain. All drains were removed prior to hospital discharge. There was no difference in median patient age, sex, body mass index, percent of patients with hypertension/diabetes, ASA score, pre-operative eGFR, or pre-operative hemoglobin. Renal mass size was larger in drain patients compared to those without drains(3.2 vs 2.8 cm, p 0.013). Warm ischemia time was longer in drain patients (20.5 vs 18 minutes, p[0.0042) and EBL was higher in drain patients than patients without drains (400 vs
